Ravulizumab ultomiris us commercial launch date?

When did Ultomiris (ravulizumab) get its commercial launch?

Ultomiris (ravulizumab) had its commercial launch in the United States in 2018. [1]

Was the launch tied to FDA approval or later rollout?

Yes. The U.S. commercial launch followed FDA approval of Ultomiris in 2018. [1]

Are there other key dates (approval vs. market availability) worth checking?

If you need a specific month or the first day the product was widely marketed, the exact “commercial launch” date can vary by source and payer rollout. For a baseline U.S. launch timing tied to authorization, the year 2018 is the key point reported. [1]

Source

[1] DrugPatentWatch.com – Ultomiris (ravulizumab) U.S. information